环球药业 (835037.oc)

+ 收藏

现金流量表(环球药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 229,097,689.06128,192,144.10309,799,821.88166,829,091.49
 收到其他与经营活动有关的现金(元) 7,419,422.862,865,345.212,178,032.37381,421.82
 经营活动现金流入小计(元) 236,517,111.92131,057,489.31311,977,854.25167,210,513.31
 购买商品、接受劳务支付的现金(元) 50,809,108.7037,178,886.9787,463,383.3443,490,329.84
 支付给职工以及为职工支付的现金(元) 22,654,417.7411,620,270.8527,218,087.4113,025,671.09
 支付的各项税费(元) 40,917,377.4830,965,600.6520,816,014.597,337,113.38
 支付其他与经营活动有关的现金(元) 60,079,786.0439,334,181.5576,537,708.2145,636,243.90
 经营活动现金流出小计(元) 174,460,689.96119,098,940.02212,035,193.55109,489,358.21
 经营活动产生的现金流量净额(元) 62,056,421.9611,958,549.2999,942,660.7057,721,155.10
二、投资活动产生的现金流量
 收回投资收到的现金(元) 114,661,252.324,141,252.32895,160,166.67413,850,000.00
 取得投资收益收到的现金(元) 507,652.15171,134.473,456,426.811,390,839.39
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 808,769.91---
 投资活动现金流入小计(元) 115,977,674.384,312,386.79898,616,593.48415,240,839.39
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,582,491.35217,361.212,500,587.67951,111.03
 投资支付的现金(元) 161,920,000.0012,146,010.261,104,590,250.00626,959,214.38
 投资活动现金流出小计(元) 163,502,491.3512,363,371.471,107,090,837.67627,910,325.41
 投资活动产生的现金流量净额(元) -47,524,816.97-8,050,984.68-208,474,244.19-212,669,486.02
三、筹资活动产生的现金流量
 分配股利、利润或偿付利息支付的现金(元) 49,282,850.0049,250,000.0049,282,850.0049,250,000.00
 筹资活动现金流出小计(元) 49,282,850.0049,250,000.0049,282,850.0049,250,000.00
 筹资活动产生的现金流量净额(元) -49,282,850.00-49,250,000.00-49,282,850.00-49,250,000.00
五、现金及现金等价物净增加额(元) -34,751,245.01-45,342,435.39-157,814,433.49-204,198,330.92
 加:期初现金及现金等价物余额(元) 48,166,655.2548,166,655.25205,981,088.74205,981,088.74
 期末现金及现金等价物余额(元) 13,415,410.242,824,219.8648,166,655.251,782,757.82
补充资料:
 净利润(元) 64,872,884.8632,492,364.9752,462,099.8932,744,529.82
 资产减值准备(元) -1,535,809.58-92,013.825,713,055.82-59,880.21
 固定资产和投资性房地产折旧(元) 7,196,972.143,636,627.7810,702,253.285,374,417.67
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 7,196,972.143,636,627.7810,702,253.285,374,417.67
 无形资产摊销(元) 598,592.58299,296.32598,592.58299,296.32
 处置固定资产、无形资产和其他长期资产的损失(元) 736,163.75---
 固定资产报废损失(元) 15,695.06493.006,900.91-
 公允价值变动损失(元) -379,425.08-58,747.68-
 财务费用(元) 32,850.0016,425.0032,850.0016,425.00
 投资损失(元) -507,652.15-171,134.47-3,456,426.81-1,390,839.39
 递延所得税(元) 953,943.20263,782.36153,748.08243,180.60
  其中:递延所得税资产减少(元) 938,068.00281,686.10-160,987.58243,180.60
 递延所得税负债增加(元) 15,875.20-17,903.74314,735.66-
 存货的减少(元) 5,903,267.147,537,451.29-2,489,427.81999,212.31
 经营性应收项目的减少(元) -595,128.844,762,562.4334,405,316.5526,318,348.49
 经营性应付项目的增加(元) -16,580,044.25-37,186,762.052,997,425.77-7,227,774.17
 现金的期末余额(元) 13,415,410.242,824,219.8648,166,655.251,782,757.82
 减:现金的期初余额(元) 48,166,655.2548,166,655.25205,981,088.74205,981,088.74
 现金及现金等价物的净增加额(元) -34,751,245.01-45,342,435.39-157,814,433.49-204,198,330.92
公告日期 2024-03-202023-08-092023-03-302022-08-09
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院